ask="2.8000"
ask_size="2600"
average_daily_volume="129153"
bid="N/A"
bid_size="N/A"
book_value="1.4000"
change="-0.0301"
change_from_200_day_moving_average="1.6052"
change_from_50_day_moving_average="0.9502"
change_from_52_week_high="-5.1996"
change_From_52_week_low="0.7199"
change_in_percent="-1.1231%"
close="2.6499"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.3000"
ebitda="-2.11M"
eps_estimate_current_year="-0.0200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0200"
ex_dividend_date="N/A"
float_shares="2160000"
high="2.7300"
high_52_weeks="7.8495"
last_trade_date="3/14/2017"
last_trade_price="2.6499"
last_trade_size="400"
last_trade_time="3:59pm"
low="2.6100"
low_52_weeks="1.9300"
market_capitalization="7.10M"
moving_average_200_day="1.0447"
moving_average_50_day="1.6997"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="30.0000"
open="2.7100"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+153.6493%"
percent_change_from_50_day_moving_average="+55.9031%"
percent_change_from_52_week_high="-66.2412%"
percent_change_from_52_week_low="+37.3005%"
previous_close="2.6800"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.9143"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.3000"
stock_exchange="NCM"
symbol="XTLB"
volume="76911"
weeks_range_52="1.9300 - 7.8495"
